Question

Difficulty: MediumOrdering Imaging Studies

A 5858-year-old man with a history of hypertension undergoes an abdominal ultrasound for mild right upper quadrant pain. The ultrasound incidentally identifies a 3.23.2-cm solid mass in the right adrenal gland. Subsequent biochemical screening for hypercortisolism, primary aldosteronism, and pheochromocytoma is entirely normal. Arrange the following diagnostic modalities in the correct evidence-based sequence for characterizing this adrenal incidentaloma, starting with the initial preferred imaging study and ending with the most invasive diagnostic step of last resort.

  1. 1Non-contrast computed tomography (CT) of the adrenal glands
  2. 2Adrenal protocol CT with delayed contrast washout imaging
  3. 3Fluorodeoxyglucose positron emission tomography (FDG-PET) scan
  4. 4Image-guided percutaneous core needle biopsy

Answer

The correct sequence for characterizing an indeterminate adrenal incidentaloma is: Non-contrast CT, followed by Adrenal protocol CT with washout, then FDG-PET scan, and finally Image-guided percutaneous biopsy.
The algorithm for evaluating an adrenal incidentaloma follows a strict sequence from least invasive and most specific for common benign lesions, to most invasive for indeterminate masses. A non-contrast CT easily identifies benign lipid-rich adenomas (the most common finding). If the mass is lipid-poor (≥10\ge 10 HU), a contrast-enhanced washout CT distinguishes rapidly washing-out adenomas from malignancies. If still indeterminate, functional imaging like an FDG-PET scan assesses metabolic activity. Finally, an image-guided biopsy is reserved solely for masses remaining indeterminate when tissue diagnosis will change the management plan.

Step-by-Step Solution

1
Identify the clinical scenario
A patient with a newly discovered, biochemically non-functioning 3.23.2-cm adrenal incidentaloma requiring radiologic characterization.
To determine the appropriate diagnostic algorithm for evaluating the malignant potential of an adrenal mass.
2
Select the initial imaging modality
Non-contrast CT of the adrenal glands is ordered first.
To measure the unenhanced tissue density. A density of <10< 10 Hounsfield units (HU) confirms a benign adenoma and halts the workup.
3
Determine the next step for indeterminate lesions
Adrenal protocol CT with delayed washout imaging is ordered.
To assess for rapid contrast washout (e.g., absolute washout >60%> 60\%), which is characteristic of lipid-poor adenomas, distinguishing them from malignancies.
4
Select the subsequent step if washout imaging is inconclusive
FDG-PET scan is utilized.
To evaluate the metabolic activity of the lesion; malignant lesions typically show high FDG avidity compared to background liver tissue.
5
Identify the modality of last resort
Image-guided percutaneous biopsy is performed.
Tissue sampling is invasive and carries severe risks; it is strictly reserved for masses that remain indeterminate after all imaging, provided pheochromocytoma has been biochemically excluded.

Key Concept

The stepwise radiologic evaluation of an adrenal incidentaloma prioritizes non-invasive characterization based on lipid content and vascular washout before considering functional imaging or invasive biopsy.

Alternative Method

Chemical shift magnetic resonance imaging (MRI) can be utilized as a direct alternative to the adrenal protocol CT with contrast washout for the second step of characterization. Chemical shift MRI detects microscopic intracellular lipid by demonstrating a diagnostic loss of signal intensity on out-of-phase images compared to in-phase images.
Estimated Time:1m 30s
Rate this question